Shield Therapeutics Partner Norgine Launches Feraccru In UK
LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday that Norgine BV has launched the company's treatment for iron deficiency, Ferracru, in the UK.In September 2018, Shield, Read More